info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Erythema elevatum diutinum

L12_ERYTHEMAELEVATUM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 L95.1
  • Cause of death: ICD-10 L95.1

2 out of 7 registries used, show all original rules.

19

4. Check minimum number of events

None

19

5. Include endpoints

None

19

6. Filter based on genotype QC (FinnGen only)

19

Control definitions (FinnGen only)

Control exclude
L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L95
Name in latin
Erythema elevatum diutinum

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 118 78 40
Only index persons 112 74 38
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population - 59.40 58.61
Only index persons 58.10 58.62 57.07

-FinnGen-

Key figures

All Female Male
Number of individuals 19 15 -
Unadjusted period prevalence (%) 0.00 0.01 -
Median age at first event (years) 63.26 63.02 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004588) Protein electrophoresis panel - Serum or Plasma
8
7
18.38
5.36
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
5
5
12.85
3.16
1.6
1.0
g/l
1.0
1.6
—
5
5
(3000494) Fungus identified in Specimen by Culture
7
17
5.85
2.66
1.9
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
18
5.50
2.54
1.1
1.5
—
—
—
0
0
(3019225) pH of Specimen
7
21
4.64
2.22
5.4
5.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
10
6.33
2.22
5.8
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
29
4.00
2.10
13.4
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
7
23
4.19
2.04
1.3
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
13
68
3.86
1.94
4.2
2.6
ug/l
146.8
98.5
0.21
13
62
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
18
4.36
1.92
2.7
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
7
25
3.82
1.87
1.7
1.1
g/l
4.3
2.4
—
7
13
(3026008) Bacteria identified in Urine by Culture
10
47
3.36
1.84
10.8
3.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5
13
4.80
1.84
2.6
1.5
ug/l
7.8
3.8
—
5
13
(40768804) Tissue Pathology biopsy report
12
68
3.06
1.59
2.7
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5
16
3.85
1.54
4.4
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
8
34
3.31
1.53
3.5
2.3
mg/l
4.9
3.5
—
8
29
(3013826) Glucose [Moles/volume] in Serum or Plasma
14
89
3.16
1.51
6.6
4.8
mmol/l
7.4
6.4
0.65
14
83
(3026493) Urate [Moles/volume] in Serum or Plasma
8
36
3.09
1.47
1.8
2.5
umol/l
322.5
334.5
—
8
29
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
18
3.38
1.38
1.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11
65
2.63
1.32
8.7
3.4
—
—
—
0
0
(3002256) Pathology report gross observation
5
21
2.85
1.17
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10
61
2.34
1.09
7.0
3.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
8
42
2.55
1.07
10.3
3.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
13
89
2.45
1.03
10.3
6.7
umol/l
9.7
9.9
0.05
13
83
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6
33
2.19
0.88
6.5
2.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
26
0.00
0.86
0.0
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
7
43
1.99
0.77
3.9
2.6
mmol/l
6.7
7.5
—
7
33
(3041096) Erythrocytes [Presence] in Urine by Automated
8
48
2.14
0.77
7.6
3.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
8
51
1.98
0.74
3.8
2.9
—
—
—
0
0
(3015736) pH of Urine
9
58
2.04
0.71
5.3
3.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
19
171
+∞
0.64
37.4
16.7
umol/l
72.2
76.7
0.48
19
171
(3023103) Potassium [Moles/volume] in Serum or Plasma
19
167
+∞
0.62
35.5
15.8
mmol/l
3.9
4.0
0.71
19
161
(3019550) Sodium [Moles/volume] in Serum or Plasma
19
167
+∞
0.62
34.8
15.6
mmol/l
138.3
140.1
1.52
19
161
(3002582) Erythrocytes [#/volume] in Urine
7
45
1.87
0.58
6.7
3.6
e6/l
9.7
15.4
—
7
37
(3011397) Hemoglobin [Presence] in Urine by Test strip
5
33
1.69
0.45
6.2
2.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
16
0.00
0.43
0.0
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5
35
1.58
0.43
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
19
173
+∞
0.43
20.5
10.5
u/l
21.2
23.4
0.47
19
167
(42870588) Differential panel, method unspecified - Blood
7
51
1.59
0.38
16.6
4.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
62
1.50
0.35
2.3
3.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
8
63
1.46
0.34
3.1
6.4
mmol/l
1.2
1.2
—
8
55
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
11
91
1.49
0.32
4.2
2.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
6
48
1.36
0.23
6.5
2.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
10
0.00
0.22
0.0
4.4
—
3.8
—
0
10
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3013512) EKG study
7
58
1.33
0.22
3.7
4.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
19
178
+∞
0.22
50.8
20.4
e12/l
4.3
4.5
0.59
19
173
(3010813) Leukocytes [#/volume] in Blood
19
178
+∞
0.22
51.0
20.5
e9/l
8.0
6.6
0.60
19
172
(36660697) Celiac disease serology panel - Serum
0
12
0.00
0.22
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
14
0.00
0.21
0.0
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
43
1.22
0.11
3.8
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
12
112
1.19
0.09
5.8
3.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
117.3
—
0
7
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
5
0.00
0.00
0.0
4.2
—
0.7
—
0
5
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
0
8
0.00
0.00
0.0
10.6
—
24.1
—
0
8
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
5
0.00
0.00
0.0
4.2
—
134.0
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
6
0.00
0.00
0.0
4.0
—
0.7
—
0
6

Mortality – FinRegistry

Association

Association between endpoint L12_ERYTHEMAELEVATUM and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHEMAELEVATUM.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: L12_ERYTHEMAELEVATUM – Erythema elevatum diutinum

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data